|
|
Volumn 27, Issue 1-2, 2008, Pages 43-69
|
|
Clinical potential of targeting Bruton's tyrosine kinase
|
|
Author keywords
BTK; Cancer; Rational drug design; Thromboembolism; Tyrosine kinases
|
|
Indexed keywords
ABELSON KINASE;
ALPHA CYANO BETA HYDROXY BETA METHYL N (2,3 DIBROMOPHENYL)PROPENAMIDE;
ASPARAGINASE;
BRUTON TYROSINE KINASE;
BRUTON TYROSINE KINASE INHIBITOR;
CD19 ANTIGEN;
CD23 ANTIGEN;
CD38 ANTIGEN;
CD5 ANTIGEN;
ENZYME INHIBITOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 4;
FAS ASSOCIATED DEATH DOMAIN PROTEIN;
FOCAL ADHESION KINASE;
FOCAL ADHESION KINASE 2;
IMATINIB;
INSULIN RECEPTOR KINASE;
JANUS KINASE 2;
JANUS KINASE 3;
LEFLUNOMIDE;
LFM A 13;
PREDNISOLONE;
PROTEIN BCL XL;
PROTEIN KINASE FES;
PROTEIN KINASE FYN;
PROTEIN KINASE LYN;
PROTEIN KINASE SYK;
PROTEIN KINASE ZAP 70;
STAT5A PROTEIN;
TOLL LIKE RECEPTOR 2;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VINCRISTINE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
APOPTOSIS;
ASTHMA;
B CELL LEUKEMIA;
BLOOD TOXICITY;
CANCER CELL CULTURE;
CANCER MODEL;
CHRONIC LYMPHATIC LEUKEMIA;
DRUG DESIGN;
DRUG TARGETING;
ENZYME INHIBITION;
GRAFT VERSUS HOST REACTION;
HUMAN;
HUMORAL IMMUNITY;
IC 50;
INNATE IMMUNITY;
LEUKEMIA;
LEUKEMOGENESIS;
LIVER TOXICITY;
PRIORITY JOURNAL;
REVIEW;
SINGLE DRUG DOSE;
THROMBOEMBOLISM;
AMIDES;
ANIMALS;
APOPTOSIS;
DRUG DESIGN;
GRAFT VS HOST DISEASE;
HUMANS;
LEUKEMIA;
NITRILES;
PROTEIN KINASE INHIBITORS;
PROTEIN-TYROSINE KINASES;
THROMBOEMBOLISM;
|
|
EID: 40049087838
PISSN: 08830185
EISSN: 15635244
Source Type: Journal
DOI: 10.1080/08830180701784588 Document Type: Review |
|
Times cited : (9)
|
|
References (170)
|
